More importantly, through the collation of clinical data, this study showed that CD36 was highly expressed on the surface of tumor-associated macrophages in lung cancer and breast cancer patients and was significantly higher than other normal tissue macrophages. The gene discussed is CD36; the disease is lung carcinoma.